These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4849136)

  • 1. [Malignant hyperthermia].
    Pöntinen PJ; Abele K; Autere T
    Duodecim; 1974; 90(1):55-8. PubMed ID: 4849136
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Malignant hyperthermia.
    Stephen CR
    South Med J; 1975 Jul; 68(7):801-2. PubMed ID: 1154068
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant hyperthermia].
    Reske-Nielsen E; Haase J
    Ugeskr Laeger; 1975 Feb; 137(7):399-400. PubMed ID: 1118942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia: biochemico-metabolic aspects and personal experiences].
    Di Prospero S; Bianchi S; Di Lazzaro M; Camilli-Giammei T
    Clin Ter; 1984 Sep; 110(6):549-53. PubMed ID: 6238769
    [No Abstract]   [Full Text] [Related]  

  • 5. A protocol for malignant hyperthermia.
    Fernsebner B
    AORN J; 1980 Apr; 31(5):814-8. PubMed ID: 6899763
    [No Abstract]   [Full Text] [Related]  

  • 6. Anesthetic malignant myopathy hyperthermia.
    Harpman JA
    Arch Otolaryngol; 1972 Sep; 96(3):264-7. PubMed ID: 5081936
    [No Abstract]   [Full Text] [Related]  

  • 7. Porcine malignant hyperthermia: a study on the triggering effects of succinylcholine.
    Nelson TE; Jones EW; Bedell DM
    Anesth Analg; 1973; 52(6):908-11. PubMed ID: 4796565
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia].
    Mehler J; Bachour H; Simons F; Wolpers K
    Anaesthesist; 1991 Sep; 40(9):497-501. PubMed ID: 1952045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant hyperthermia following nitrous oxide-halothane anesthesia].
    Stovner J; Sundt T; Mohr B; Lilleaasen P
    Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1512-6. PubMed ID: 1179364
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia in a Greyhound.
    Bagshaw RJ; Cox RH; Knight DH; Detweiler DK
    J Am Vet Med Assoc; 1978 Jan; 172(1):61-2. PubMed ID: 624662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations.
    Lewandowski KB
    Br J Anaesth; 1981 Sep; 53(9):981-4. PubMed ID: 7284224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant hyperthermia--clinical aspects and treatment of life-endangering complications of anesthesia].
    Purschke R; Zindler M
    Chirurg; 1974 Oct; 45(10):472-6. PubMed ID: 4462988
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant hyperthermia: a catastrophic complication.
    Ryan JF; Kerr WS
    J Urol; 1973 May; 109(5):879-83. PubMed ID: 4699690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant hyperthermia].
    Popinigis J; Brucker RF; Taylor CA; Williams CH
    Pol Tyg Lek; 1972 Aug; 27(33):1290-3. PubMed ID: 4562245
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
    Fletcher JE; Rosenberg H; Lizzo FH
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):187-92. PubMed ID: 2728821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia.
    Tsang HS; Schoenfeld FG
    IMJ Ill Med J; 1976 May; 149(5):471-3. PubMed ID: 6381
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant hyperthermia syndrome].
    Garstka J; Wierusz L
    Chir Narzadow Ruchu Ortop Pol; 1974; 39(4):467-70. PubMed ID: 4410062
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperthermia associated with ophthalmic surgery.
    Beasley H
    Am J Ophthalmol; 1974 Jan; 77(1):76-9. PubMed ID: 4596135
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
    Hogan KJ; Vladutiu GD
    Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.